Chlamydia, The Most-Common Infection In the USA
The first time chlamydia was included by state epidemiologists in an annual listing of diseases in the USA, it was ranked as the most-common infectious disease affecting Americans in 1995. The Centers for Disease Control report labeled gonorrhea and AIDS as number two and three, respectively.
In 1995, there were 477,638 cases of chlamydia. Gonorrhea, the most-commonly reported disease in 1994, fell to 392,848 cases in 1995 compared with 418,068 cases the year earlier. AIDS, which held the number two spot in 1994, dropped to 71,547 cases from 78,279 in 1994. Along with syphilis and hepatitis B, these diseases accounted for 87% of the total cases caused by the top 10 diseases, according to the report.
Chlamydia was most common among women, affecting 383,965 in 1995, while gonorrhea and AIDS were both reported by more men, with 203,563 and 58,007 cases in 1995, respectively.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze